PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: VM Discovery, Inc. (VMD)

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

VM Discovery and Fred Hutchinson Cancer Research Center Team on Cancer Drug Discovery - VM Discovery, Inc. (VMD), a drug-design and discovery company, and Fred Hutchinson Cancer Research Center today announced they have entered into a collaboration to jointly pursue a cancer-drug discovery program
VM Discovery and Fred Hutchinson Cancer Research Center Team on Cancer Drug Discovery

 

NewswireToday - /newswire/ - Fremont, CA, United States, 2006/03/29 - VM Discovery, Inc. (VMD), a drug-design and discovery company, and Fred Hutchinson Cancer Research Center today announced they have entered into a collaboration to jointly pursue a cancer-drug discovery program.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

VM Discovery and Fred Hutchinson Cancer Research Center Team on Cancer Drug Discovery; Collaboration Focuses on Compounds Against an Important Cancer Pathway.

VM Discovery Inc. (VMD), a drug-design and discovery company, and Fred Hutchinson Cancer Research Center today announced they have entered into a collaboration to jointly pursue a cancer-drug discovery program. Under the collaboration, VMDI will use its proprietary multi-property drug design and optimization technology platform, the “VM OptimizerTM, to generate and optimize small-molecule ”drug-like” leads and clinical candidates, while the Hutchinson Center will leverage its expertise in cancer biology and proprietary technologies. Other terms of the collaboration were not disclosed.

“It is exciting to collaborate with the distinguished scientists and professionals at the Hutchinson Center to translate their strong and unique cancer-biology knowledge to the drug-able molecules for the potential breakthrough treatment of cancers,” said Jay Wu, president and CEO of VM Discovery Inc. “Having a successful track record with our industry clients, academic research institutes and our internal drug-discovery programs, we are confident that our proprietary technology platform will allow us to design and optimize advanced small-molecule drug candidates against an important cancer pathway .“

This is the Hutchinson Center’s first collaboration with the chemistry industry this year. “We are excited about this collaboration,” said Spencer Lemons, vice president of Industry Relations and Technology Transfer at the Hutchinson Center. “Bringing together our world-class research with the drug-discovery expertise of industry helps in our mission to eliminate cancer as a cause of human suffering and death.”

About VM Discovery Inc. (VMD)
VM Discovery Inc. (vmdiscovery.com) is a privately held, venture-backed drug discovery company located in Silicon Valley, California. The company has developed proprietary drug design and optimization technology “the “VM Optimizer™”) to discover novel, potent small-molecule drug leads with balanced ADMET (absorption, distribution, metabolism, elimination and toxicity) properties in various therapeutic arenas. VMD has been developing a portfolio of optimized preclinical drug candidates, including new uses of old drugs, in various disease areas including cancer, diabetes and neurological diseases. In addition, VMD has been a source of optimized molecules to drug development companies for out-licensing, sale or “compound partnering” purposes. VMD has ongoing drug discovery collaboration with biotechnology and pharmaceutical companies as well as prominent academic/research institutes.

About Fred Hutchinson Cancer Research Center
The Hutchinson Center’s interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Center researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: VM Discovery, Inc. (VMD)

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


VM Discovery and Fred Hutchinson Cancer Research Center Team on Cancer Drug Discovery

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jay Wu - VMDiscovery.com 
510-360-7224 info[.]vmdiscovery.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any VM Discovery, Inc. (VMD) securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From VM Discovery, Inc. (VMD) / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  S&A Capital Partner Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)